Search Results for keywords:"biological product manufacturing"

Search Results: keywords:"biological product manufacturing"

H. R. 661 — To require the Secretary of Health and Human Services, in consultation with the Secretary of Commerce, the Council for Technology and Innovation of the Centers for Medicare & Medicaid Services, and the Commissioner of Food and Drugs, to carry out a program to facilitate and coordinate efforts between the United States and Israel to expand and enhance collaboration on the development and delivery of health care products and services.
💰
January 23, 2025
Status:Introduced in House
Congress:119
Words:1,248
H. R. 661, also known as the “Maximizing Israel-U.S. Research Advancement and Collaborative Leadership in Emerging Medical Technology Act of 2025” or the “MIRACLE Medical Technology Act of 2025,” aims to establish a program to enhance collaboration between the United States...
Simple Explanation
The MIRACLE Medical Technology Act of 2025 is a plan where the United States and Israel team up to make health care better by working together on new medical technology, sharing knowledge, and improving health services with a budget of $8 million per year from 2026 to 2030.

Showing 1 to 1 of 1 results